Home / Pharmaceutical / Global In-vitro Diagnostics Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2016 To 2022

Global In-vitro Diagnostics Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2016 To 2022

Published: May 2016 | Published By: Acute Market Research

Global In-vitro Diagnostics Market - Growth, Opportunities, Competitive Analysis, and Forecast, 2016 - 2022, the in-vitro diagnostics market was valued at USD 60,468.7 Mn in 2015, and is expected to reach USD 81,345.1 Mn by 2022, expanding at a CAGR of 4.2% from 2016 to 2022.

Market Insights
The need for in-vitro diagnostics is on a consistent rise due to growing incidence of chronic diseases, infections and high risk ageing population. Growing scope of personalized medicine, molecular diagnostics and growing knowledge about exploration of rare diseases and their treatments are further supporting the growth of in-vitro diagnostics market. On the other hand, rigorous regulatory requirements and dicey reimbursements will hold back the hold of this market.
Reagents, instruments, and software and services is the product level segmentation of the global in-vitro diagnostics market. Among these, reagents take over 30% of the overall market share in 2015, due to large scale consumption of these products across all IVS techniques. Additionally, the software and services segment is anticipated to progress at a faster growth rate during the forecast period attributed by the growing need for widest automation and centralization of IVD processes and techniques at a precision at par.
Molecular diagnostics is observed to be the most remarkable IVD technique during the forecast period. Growing applicability of MDx is attributed to its efficacy in understanding disease mechanism and thus their vital role in discovery of appropriate and targeted treatments. Its prospects in novel drug discovery and personalized medicine also plays a critical role in facilitating lucrative market growth during the forecast period. IVD is largely performed in central laboratories, whereas its applicability in point-of-care testing is on a perpetual growth. However, over-the-counter or self testing IVD will demonstrate the most significant growth rate in the near future with the growing number of OTC testing products while offering cost effectiveness and precise outcomes.
Geographically, North America is the largest in-vitro diagnostics market, with the region taking over 35% market share in 2015. Fastest adoption of advanced technologies and rapid adoption of automation techniques in diagnostic process are the prime features of North America IVD market. Growing preference for molecular diagnostic in cancer screening will also facilitate steady growth to North America and Europe in-vitro diagnostics markets.
This market is majorly dominated with 5 players taking over 5% market share. This market is currently undergoing large scale consolidation activities by multinational players. Emergence of regional players is another significant phenomenon in the global in-vitro diagnostics market. Some of the major market players include Abbott Laboratories, Inc., Johnson and Johnson, Becton, Dickson and Company, Danaher Corporation, bioMérieux, Thermo Fisher Scientific, Inc. Sysmex Corporation and others.

Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology

Chapter 2 Executive Summary
2.1 In-vitro Diagnostics Market Share, by Products, 2015 & 2022 (Value %)
2.2 In-vitro Diagnostics Market, by Techniques, 2015 (USD Mn)
2.3 In-vitro Diagnostics Market, by Test Locations, 2015 (USD Mn)
2.4 In-vitro Diagnostics Market Share, by Geography, 2015 (Value %)

Chapter 3 In-vitro Diagnostics Market: Market Dynamics and Outlook
3.1 Introduction, Facts and Figures
3.2 Drivers
3.3 Challenges
3.4 Future Prospects
3.5 Attractive Investment Proposition
3.1 Competitive Analysis: Fractal Map Investigation, by Key Market Players

Chapter 4 Global In-vitro Diagnostics Market Analysis, by Products
4.1 Preface
4.2 Reagents
4.3 Instruments
4.4 Software and Services

Chapter 5 Global In-vitro Diagnostics Market Analysis, by Techniques
5.1 Preface
5.2 Clinical Chemistry
5.3 Immunochemistry/Immunoassays
5.4 Hematology
5.5 Coagulation and Hemostasis
5.6 Microbiology
5.7 Molecular Diagnostics (MDX)
5.8 Others

Chapter 6 Global In-vitro Diagnostics Market Analysis, by Test Locations
6.1 Preface
6.2 Point-of-Care Testing
6.3 Central Lab Testing
6.4 OTC/Self Testing

Chapter 7 Global In-vitro Diagnostics Market, by Geography
7.1 Preface
7.2 North America
7.3 Europe
7.4 Asia-Pacific
7.5 Middle East and Africa (MEA)
7.6 Latin America

Chapter 8 Company Profiles
8.1 Abbott Laboratories, Inc.
8.1.1 Business Description
8.1.2 Financial Health and Budget Allocation
8.1.3 Product Positions/Portfolio
8.1.4 News Coverage
8.2 Bayer AG.
8.2.1 Business Description
8.2.2 Financial Health and Budget Allocation
8.2.3 Product Positions/Portfolio
8.2.4 News Coverage
8.3 Becton, Dickson and Company
8.3.1 Business Description
8.3.2 Financial Health and Budget Allocation
8.3.3 Product Positions/Portfolio
8.3.4 News Coverage
8.4 bioMérieux
8.4.1 Business Description
8.4.2 Financial Health and Budget Allocation
8.4.3 Product Positions/Portfolio
8.4.4 News Coverage
8.5 Bio-Rad Laboratories, Inc.
8.5.1 Business Description
8.5.2 Financial Health and Budget Allocation
8.5.3 Product Positions/Portfolio
8.5.4 News Coverage
8.6 Danaher Corporation
8.6.1 Business Description
8.6.2 Financial Health and Budget Allocation
8.6.3 Product Positions/Portfolio
8.6.4 News Coverage
8.7 Johnson & Johnson Pvt Ltd.
8.7.1 Business Description
8.7.2 Financial Health and Budget Allocation
8.7.3 Product Positions/Portfolio
8.7.4 News Coverage
8.8 Roche Diagnostics
8.8.1 Business Description
8.8.2 Financial Health and Budget Allocation
8.8.3 Product Positions/Portfolio
8.8.4 News Coverage
8.9 Siemens AG
8.9.1 Business Description
8.9.2 Financial Health and Budget Allocation
8.9.3 Product Positions/Portfolio
8.9.4 News Coverage
8.10 Sysmex Corporation
8.10.1 Business Description
8.10.2 Financial Health and Budget Allocation
8.10.3 Product Positions/Portfolio
8.10.4 News Coverage
8.11 Others
8.11.1 Business Description
8.11.2 Financial Health and Budget Allocation
8.11.3 Product Positions/Portfolio
8.11.4 News Coverage

TABLE 1 Global In-vitro Diagnostics Market, by Products, 2014 – 2022 (USD Mn)
TABLE 2 Global In-vitro Diagnostics Market, by Techniques, 2014 – 2022 (USD Mn)
TABLE 3 Global In-vitro Diagnostics Market, by Test Locations, 2014 – 2022 (USD Mn)
TABLE 4 Global In-vitro Diagnostics Market, by Geography, 2014 – 2022 (USD Mn)
TABLE 5 North America In-vitro Diagnostics Market, by Country, 2014 – 2022 (USD Mn)
TABLE 6 Europe In-vitro Diagnostics Market, by Country, 2014 – 2022 (USD Mn)
TABLE 7 Asia-Pacific In-vitro Diagnostics Market, by Country, 2014 – 2022 (USD Mn)

FIG. 1 In-vitro Diagnostics: Market Segmentation
FIG. 2 In-vitro Diagnostics Market Share, by Products, 2015 & 2022 (Value %)
FIG. 3 In-vitro Diagnostics Market, by Techniques, 2015 (USD Mn)
FIG. 4 In-vitro Diagnostics Market, by Test Locations, 2015 (USD Mn)
FIG. 5 In-vitro Diagnostics Market Share, by Geography, 2015 (Value %)
FIG. 6 Attractive Investment Proposition, In-vitro Diagnostics Market, 2015
FIG. 7 Competitive Analysis: Fractal Map Investigation, by Key Market Players
FIG. 8 Global IVD Reagents Market, 2014 – 2022 (USD Mn)
FIG. 9 Global IVD instruments Market, 2014 – 2022 (USD Mn)
FIG. 10 Global IVD Software and Services Market, 2014 – 2022 (USD Mn)
FIG. 11 Global Clinical Chemistry IVD Market, 2014 – 2022 (USD Mn)
FIG. 12 Global Immunochemistry/Immunoassays IVD Market, 2014 – 2022 (USD Mn)
FIG. 13 Global Hematology IVD Market, 2014 – 2022 (USD Mn)
FIG. 14 Global Coagulation and Hemostasis IVD Market, 2014 – 2022 (USD Mn)
FIG. 15 Global Microbiology IVD Market, 2014 – 2022 (USD Mn)
FIG. 16 Global Molecular Diagnostics (MDX) IVD Market, 2014 – 2022 (USD Mn)
FIG. 17 Global Other IVD Techniques IVD Market, 2014 – 2022 (USD Mn)
FIG. 18 Global IVD in Point-of-Care Testing Market, 2014 – 2022 (USD Mn)
FIG. 19 Global IVD in Central Lab Testing Market, 2014 – 2022 (USD Mn)
FIG. 20 Global IVD in OTC/Self Testing Market, 2014 – 2022 (USD Mn)
FIG. 21 U.S. In-vitro Diagnostics Market, 2014 - 2022 (USD Mn)
FIG. 22 Canada In-vitro Diagnostics Market, 2014 - 2022 (USD Mn)
FIG. 23 U.K. In-vitro Diagnostics Market, 2014 - 2022 (USD Mn)
FIG. 24 Germany In-vitro Diagnostics Market, 2014 - 2022 (USD Mn)
FIG. 25 Rest of Europe In-vitro Diagnostics Market, 2014 - 2022 (USD Mn)
FIG. 26 Japan In-vitro Diagnostics Market, 2014 - 2022 (USD Mn)
FIG. 27 China In-vitro Diagnostics Market, 2014 - 2022 (USD Mn)
FIG. 28 Rest of Asia-Pacific In-vitro Diagnostics Market, 2014 - 2022 (USD Mn)
FIG. 29 Middle East and Africa In-vitro Diagnostics Market, 2014 - 2022 (USD Mn)
FIG. 30 Latin America In-vitro Diagnostics Market, 2014 - 2022 (USD Mn)

Choose License Type
 
Contact Information
24/7 Research Support
Phone: +1-855-455-8662
sales@acutemarketreports.com
Get in Touch with us
join us on Facebook
Follow us on Twitter
Follow us on LinkedIn
Add us on Google +